SHAREHOLDER ALERT: iLearningEngines Investigated for Securities Fraud Violations by Block & Leviton
September 12, 2024 16:04 ET
|
Block & Leviton LLP
Block & Leviton is investigating iLearningEngines (Nasdaq: AILE) for potential securities fraud. Investors who have lost money should contact the firm.
Eguana Announces Second Quarter 2024 Financial Results
August 29, 2024 16:00 ET
|
Eguana Technologies Inc.
CALGARY, Alberta, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Eguana Technologies Inc. (TSXV: EGT) (OTCQB: EGTYF) (“Eguana” or the “Company”), a leading provider of high-performance energy storage systems,...
SHARC Energy Announces Q2 2024 Financial Results
August 29, 2024 08:00 ET
|
SHARC Energy
VANCOUVER, British Columbia, Aug. 29, 2024 (GLOBE NEWSWIRE) -- SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) ("SHARC Energy" or the “Company”) is pleased to announce it has...
Novonesis delivers strong half-year results and increases full-year outlook
August 27, 2024 10:34 ET
|
Novozymes A/S
In the first half of 2024, Novonesis delivered 7% organic sales growth with an adjusted EBITDA margin at 35.3%. Following strong first half-year performance, Novonesis increases its full-year organic...
Cornish Metals Releases Unaudited Financial Statements and Management’s Discussion and Analysis For the Six Months Ended 30 June 2024
August 15, 2024 02:00 ET
|
Cornish Metals Inc.
Cornish Metals releases unaudited financial statements and management's discussion and analysis for the six months ended 30 June 2024
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 14, 2024 16:05 ET
|
Fractyl Health, Inc.
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates
Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates
August 08, 2024 16:05 ET
|
Assembly Biosciences, Inc.
Dosing initiated in healthy participants in Phase 1a/b trial for ABI-5366 targeting recurrent genital herpes, with interim Phase 1a first-in-human data expected in Q3 2024 and interim Phase 1b data in...
Orezone Reports Second Quarter 2024 Results
August 06, 2024 18:32 ET
|
Orezone Gold Corporation
VANCOUVER, British Columbia, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone” or “Company”) reported its operational and financial results for the three...
Orezone Provides Notice of Q2-2024 Results and Conference Call
July 29, 2024 12:23 ET
|
Orezone Gold Corporation
VANCOUVER, British Columbia, July 29, 2024 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone”) will announce its second quarter 2024 results on August 6, 2024, after...
Cannara Biotech Reports Q3 2024 Financial Results
July 23, 2024 08:30 ET
|
Cannara Biotech (Québec) Inc.
Net revenues up 22.6% to $19.5M, positive Adjusted EBITDA of $2.8M and operating cash flows of $4.3 million. Focused on the Canadian Cannabis Opportunity